Granulocyte colony stimulating factor increases the efficacy of conventional amphotericin in the treatment of presumed deep-seated fungal infection in neutropenic patients following intensive chemotherapy or bone marrow transplantation for haematological malignancies

Hematology

Volumn 4, Issue 4, 1999, Pages 305-311

  Hazel, D L ^a   Newland, A C ^a   Kelsey, S M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amphotericin; Fungal infection; GMCSF; Growth factor; Neutropenic

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CORTICOSTEROID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; DRUG EFFICACY; FEMALE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELOMA; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RASH; RIGOR; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0033395970     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.1999.11746453     Document Type: Article

References (28)